A novel endovascular strategy to target severe calcified occlusions, the so-called “pave-and-crack” technique, was the focus of a presentation by Manuela Matschuck, MD, from University Hospital Leipzig.

“Catheter-directed intra-arterial thrombolysis is a rational and well-used method for therapy of chronic limb ischemia (CLI) patients with thrombotic occlusions of lower extremity arteries or bypass grafts,” said Ulrich Beschorner, MD.

Robert Lookstein, MD (Icahn School of Medicine at Mount Sinai, New York City) presented 10-year findings of the LONG DES-BTK study of the use of drug-eluting stents (DES) in the treatment of BTK disease.

Peter Schneider, MD, discussed the latest investigational device exemption (IDE) study of the DETOUR System, dubbed the US IDE DETOUR II Clinical Trial, which is currently recruiting across 37 sites in the U.S., Germany, Poland, and Latvia.

A discussion of the COMPARE trial 12-month data, presented for the first time by Sabine Steiner, MD.

(Leipzig, Germany) January 29, 2020 -- Two-year registry data on the LimFlow (LimFlow SA, France) percutaneous deep vein arterialization (pDVA) system were presented by Andrej Schmidt, MD (University Hospital Leipzig, Germany) in a first-time data…

Two-year results of the Lutonix registry were presented on Wednesday by Dierk Scheinert, MD, who is the study’s co-principal investigator alongside Michael Lichtenberg, MD.

(Leipzig, Germany) January 29, 2020 -- First-time data on ‘Advancing laser therapy: Different settings for different lesions’ was presented on Tuesday morning by George Adams, MD (University of North Carolina Medical Center, Raleigh, NC), who walked…

(Leipzig, Germany) January 29, 2020 -- Continuing the series of first-time data releases at LINC, Patrick J. Geraghty, MD (Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, MO) presented 12-month data of the Lutonix…